The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study

The Value of OCT and OCTA as Potential Biomarkers for Preclinical Alzheimer’s Disease: A Review Study

Preclinical Alzheimer’s disease (AD) includes cognitively healthy subjects with at least one positive biomarker: reduction in cerebrospinal fluid Aβ<sub>42</sub> or visualization of cerebral amyloidosis by positron emission tomography imaging. The use of these biomarkers is expensive, in...

Full description

Bibliographic Details
Main Authors: Inés López-Cuenca, Elena Salobrar-García, Lorena Elvira-Hurtado, José A. Fernández-Albarral, Lidia Sánchez-Puebla, Juan J. Salazar, José M. Ramírez, Ana I. Ramírez, Rosa de Hoz
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Life
Subjects:
Alzheimer’s disease
preclinical
optical coherence tomography
optical coherence tomography-angiography
retina
biomarker
Online Access:https://www.mdpi.com/2075-1729/11/7/712

Internet

https://www.mdpi.com/2075-1729/11/7/712

Similar Items